SURGICAL MANAGEMENT OF FIGO STAGE IV EPITHELIAL OVARIAN CANCER VERSUS FIGO STAGE IIIC: THE REAL-WORLD EXPERIENCE FROM KEM

被引：1
|
作者：
Tsibulak, Irina [1 ]
Moubarak, Malak [1 ]
Schneider, Stephanie [1 ]
Traut, Alexander [1 ]
Welz, Julia [1 ]
Concin, Nicole [1 ]
Bommert, Mareike [1 ]
Vrentas, Vasileios [1 ]
Zdanyte, Kristina [1 ]
Bennefeld, Luisa [1 ]
Kaiser, Sabrina [1 ]
Westermann, Timo [1 ]
Heitz, Florian [1 ]
Harter, Philipp [1 ]
机构：
[1] Kiliniken Essen Mitte, Essen, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
644
引用
收藏
页码：A37 / A38
页数：2
相关论文
共 50 条
  • [41] CYTOREDUCTIVE SURGERY IN STAGE IIIC AND IV EPITHELIAL OVARIAN CANCER, A PROSPECTIVE COHORT STUDY
    Mitsopoulos, V.
    Innamaa, A.
    Lippiatt, J.
    Plevris, N.
    Biliatis, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A496 - A496
  • [42] Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
    Luo, Yanlin
    Lee, Maria
    Kim, Hee Seung
    Chung, Hyun Hoon
    Song, Yong Sang
    MEDICINE, 2016, 95 (36)
  • [43] 30 Years of Experience in the Management of Stage III and IV Epithelial Ovarian Cancer: Impact of Surgical Strategies on Survival
    Delga, Berenice
    Classe, Jean-Marc
    Houvenaeghel, Gilles
    Blache, Guillaume
    Sabiani, Laura
    El Hajj, Houssein
    Andrieux, Nicole
    Lambaudie, Eric
    CANCERS, 2020, 12 (03)
  • [44] Localization of distant metastases defines prognosis and treatment efficacy in patients with FIGO stage IV ovarian cancer
    Timmermans, Maite
    Sonke, G. S.
    Van de Vijver, K. K.
    Ottevanger, P. B.
    Nijman, H. W.
    van der Aa, M. A.
    Kruitwagen, R. F. P. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (02) : 392 - 397
  • [45] Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study
    Bolis, Giorgio
    Scarfone, Giovanna
    Raspagliesi, Francesco
    Mangili, Giorgia
    Danese, Saverio
    Scollo, Paolo
    Lo Russo, Domenica
    Villa, Antonella
    Aimone, Paola Daniela
    Scambia, Giovanni
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2905 - 2912
  • [46] Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in FIGO Stage III and IV Epithelial Ovarian, Tubal or Peritoneal Cancer: A Systematic Review and Meta-Analysis
    Tzanis, Alexander A.
    Iavazzo, Christos
    Hadjivasilis, Alexandros
    Tsouvali, Hara
    Antoniou, George A.
    Antoniou, Stavros A.
    ONCOLOGY REVIEWS, 2022, 16
  • [47] A RETROSPECTIVE STUDY OF ADJUVANT CHEMOTHERAPY PLUS PELVIC RADIOTHERAPY IN FIGO STAGE II EPITHELIAL OVARIAN CANCER
    Chamoun, J.
    Au-Yeng, G.
    te Marvelde, L.
    Quinn, M.
    Grant, P.
    McNally, O.
    Narayan, K.
    Rischin, D.
    Neesham, D.
    Allen, D.
    Hyde, S.
    Bernshaw, D.
    Khaw, P.
    Mileshkin, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 175 - 176
  • [48] CARBOPLATIN VERSUS SEQUENTIAL IFOSFAMIDE CARBOPLATIN FOR PATIENTS WITH FIGO STAGE-III EPITHELIAL OVARIAN-CARCINOMA
    PERREN, TJ
    TAN, S
    FRYATT, I
    HARPER, P
    SLEVIN, M
    WILTSHAW, E
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 518 - 518
  • [49] Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer
    Hoff, John
    Baldwin, Lauren
    Lefringhouse, Jason
    Pavlik, Edward
    Miller, Rachel
    DeSimone, Christopher
    Ueland, Frederick
    Tucker, Thomas
    Kryscio, Richard
    van Nagell, J. R.
    JOURNAL OF ONCOLOGY, 2014, 2014
  • [50] Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer
    Zivanovic, Oliver
    Sima, Camelia S.
    Iasonos, Alexia
    Bell-McGuinn, Katherine M.
    Sabbatini, Paul J.
    Leitao, Mario M.
    Levine, Douglas A.
    Gardner, Ginger J.
    Barakat, Richard R.
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2009, 115 (02) : 209 - 214
12345